The DOI matches its OpenAlex record; 16 of the 16 references it cites were found in a registry or an index.
China cardiovascular diseases report 2018: an updated summary.
Open accessAbstract
Rapid socioeconomic progress has greatly affected the lifestyle in China. Consequently, owing to lifestyle changes, urbanization, and accelerated population aging, the risk of cardiovascular diseases (CVD) has increased. The incidence of CVD has been increasing continuously and this upward trend is projected to continue in the next decade. The growing burden of CVD has become a major public health issue. Accordingly, since 2005, the National Center for Cardiovascular Diseases of China has directed experts in cardiology, neurology, nephrology, diabetes, epidemiology, community healthcare, health economics, biostatistics, and other related fields to prepare the annual Report on Cardiovascular Diseases in China. This report aims to provide a timely review of the growing epidemic of CVD in the country as well as to assess the progress made in its prevention and control. We present herein an updated summary of the Report on Cardiovascular Diseases in China 2018 that includes trends in CVD, the morbidity and mortality of CVD, risk factor assessment, health resources for CVD, and a profile of medical expenditure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, J., Li, X., Wang, Q., Hu, S., Wang, Y., Masoudi, F. A., Spertus, J. A., Krumholz, H. M., & Jiang, L. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60921-1 · Cited by 431
Self-citationRetractedPrevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
Yang, G., Wang, Y., Zeng, Y., Gao, G. F., Liang, X., Zhou, M., Wan, X., Yu, S., Jiang, Y., Naghavi, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61097-1 · Cited by 1,982
Self-citationPrevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013
Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., Li, Y., Zhao, Z., Qin, X., Jin, D., et al. (2017) · JAMA · doi:10.1001/jama.2017.7596 · Cited by 1,844
Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015
Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., Shao, L., Tian, Y., Dong, Y., Zheng, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032380 · Cited by 1,698
Self-citationWang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., Wen, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30841-9 · Cited by 1,681
Self-citationThe prevalence, awareness, treatment and control of dyslipidemia among adults in China
Pan, L., Yang, Z., Wu, Y., Yin, R.-X., Liao, Y., Wang, J., Gao, B., & Zhang, L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.006 · Cited by 402
Zhang, Y., Zhang, J., Butler, J., Yang, X., Xie, P., Guo, D., Wei, T., Yu, J., Wu, Z., Gao, Y., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.09.014 · Cited by 267
Self-citationZhang, M., Deng, Q., Wang, L., Huang, Z., Zhou, M., Li, Y., Zhao, Z., Zhang, Y., & Wang, L. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.069 · Cited by 253
Metabolic Syndrome among Adults in China - The 2010 China Noncommunicable Disease Surveillance
Lu, J., Wang, L., Li, M., Xu, Y., Jiang, Y., Wang, W., Li, J., Mi, S., Zhang, M., Li, Y., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2477 · Cited by 234
Cited by
COVID-19 and comorbidities: Deleterious impact on infected patients
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.014 · Cited by 996
Dorjee, K., Kim, H., Bonomo, E., & Dolma, R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0243191 · Cited by 216
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion
Wang, J.-Q., Li, L.-L., Hu, A., Deng, G., Wei, J., Li, Y.-F., Liu, Y.-B., Lu, X.-Y., Qiu, Z.-P., Shi, X.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-05006-3 · Cited by 188
Structural basis for sterol sensing by Scap and Insig
Yan, R., Cao, P., Song, W., Li, Y., Wang, T., Qian, H., Yan, C., & Yan, N. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109299 · Cited by 43
The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis
Zhang, S., Ding, Y., Feng, F., & Gao, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.938540 · Cited by 13
Metadata
- Authors
- Ma, L., Chen, W., Gao, R.-L., Liu, L., Zhu, M., Wang, Y., Wu, Z., Li, H., Gu, D., Yang, Y., Zheng, Z., & Hu, S.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2020-01-01
- Volume
- 17
- Issue
- 1
- Pages
- 1-8
- OpenAlex
- W3004399337
- Cited by
- 399
- References
- 16
- FWCI
- 43.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: China cardiovascular diseases report 2018: an updated summary. https://app.cochat.ai/papers/10.11909/j.issn.1671-5411.2020.01.001
- The paper
- Ma, L., Chen, W., Gao, R.-L., Liu, L., Zhu, M., Wang, Y., Wu, Z., Li, H., Gu, D., Yang, Y., Zheng, Z., & Hu, S. (2020). China cardiovascular diseases report 2018: an updated summary. PubMed. https://doi.org/10.11909/j.issn.1671-5411.2020.01.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.